Avadel Pharmaceuticals (AVDL)
(Delayed Data from NSDQ)
$15.51 USD
-0.23 (-1.46%)
Updated Aug 9, 2024 04:00 PM ET
After-Market: $15.51 0.00 (0.00%) 7:58 PM ET
3-Hold of 5 3
F Value C Growth A Momentum C VGM
Detailed Estimates
EPS Estimates
Exp Earnings Date | 11/13/24 |
---|---|
Current Quarter | -0.07 |
EPS Last Quarter | -0.14 |
Last EPS Surprise | 17.65% |
ABR | 1.10 |
Earnings ESP
|
-43.18% |
---|---|
Current Year | -0.55 |
Next Year | 0.56 |
EPS (TTM) | -1.17 |
P/E (F1) | NA |
Sales Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | 48.14M | 58.18M | 172.11M | 300.32M |
# of Estimates | 5 | 5 | 5 | 5 |
High Estimate | 52.70M | 65.99M | 184.44M | 333.70M |
Low Estimate | 45.00M | 52.00M | 161.20M | 248.00M |
Year ago Sales | 7.01M | 19.45M | 27.96M | 172.11M |
Year over Year Growth Est. | 586.68% | 199.12% | 515.48% | 74.50% |
Earnings Estimates
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Zacks Consensus Estimate | -0.07 | 0.00 | -0.55 | 0.56 |
# of Estimates | 6 | 6 | 7 | 6 |
Most Recent Consensus | -0.10 | 0.02 | -0.69 | 0.78 |
High Estimate | 0.01 | 0.11 | -0.29 | 1.05 |
Low Estimate | -0.14 | -0.09 | -0.74 | -0.03 |
Year ago EPS | -0.41 | -0.32 | -2.00 | -0.55 |
Year over Year Growth Est. | 82.93% | 100.00% | 72.50% | 201.17% |
Agreement - Estimate Revisions
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Up Last 7 Days | 1 | 1 | 1 | 0 |
Up Last 30 Days | 2 | 2 | 2 | 0 |
Up Last 60 Days | 2 | 2 | 2 | 0 |
Down Last 7 Days | 0 | 1 | 0 | 3 |
Down Last 30 Days | 0 | 1 | 0 | 3 |
Down Last 60 Days | 0 | 1 | 0 | 2 |
Magnitude - Consensus Estimate Trend
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Current | -0.07 | 0.00 | -0.55 | 0.56 |
7 Days Ago | -0.08 | 0.01 | -0.57 | 0.60 |
30 Days Ago | -0.08 | 0.01 | -0.58 | 0.60 |
60 Days Ago | -0.08 | 0.01 | -0.58 | 0.61 |
90 Days Ago | -0.08 | 0.01 | -0.58 | 0.61 |
Upside - Most Accurate Estimate Versus Zacks Consensus
Current Qtr (9/2024) |
Next Qtr (12/2024) |
Current Year (12/2024) |
Next Year (12/2025) |
|
---|---|---|---|---|
Most Accurate Estimate | -0.11 | -0.01 | -0.64 | 0.65 |
Zacks Consensus Estimate | -0.07 | 0.00 | -0.55 | 0.56 |
Earnings ESP | -43.18% | -300.00% | -16.06% | 16.52% |
Surprise - Reported Earnings History
Quarter Ending (6/2024) |
Quarter Ending (3/2024) |
Quarter Ending (12/2023) |
Quarter Ending (9/2023) |
Average Surprise | |
---|---|---|---|---|---|
Reported | -0.14 | -0.30 | -0.32 | -0.41 | NA |
Estimate | -0.17 | -0.25 | -0.28 | -0.35 | NA |
Difference | 0.03 | -0.05 | -0.04 | -0.06 | -0.03 |
Surprise | 17.65% | -20.00% | -14.29% | -17.14% | -8.45% |
Quarterly Estimates By Analyst
Zacks Premium Subscription Required Learn more
Annual Estimates By Analyst
Zacks Premium Subscription Required Learn more